Testing effectiveness (Phase 2)Not Yet RecruitingNCT07670156
What this trial is testing
Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
Who this might be right for
JAK1 GOFSTAT1 GOFSTAT3 GOF+2 more
Lisa Satter 30
Showing 14 of 14 results